BioLife Solutions, Inc.BLFSNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-57.91%
↓ 237% below average
Average (9y)
42.38%
Historical baseline
Range
High:217.41%
Low:-57.91%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -57.91% |
| 2023 | 27.02% |
| 2022 | 25.21% |
| 2021 | 75.88% |
| 2020 | 63.11% |
| 2019 | 217.41% |
| 2018 | 8.80% |
| 2017 | -41.20% |
| 2016 | 47.16% |
| 2015 | 58.28% |